The Brexit Clock is Ticking, Are You Ready?
With Brexit only months away, CTA’s Charlie Abrines explains why the pharmaceutical industry...
-
![shutterstock_194807486]()
Industry Viewpoints: Investigator-Initiated Studies – A Challenge for Supply with IMPs?
-
![shutterstock_242481727]()
Serialization of Prescription Drugs: Readiness from Development into Commercialization
-
![shutterstock_776832391_2]()
The Million Dollar Question – How can Technology Improve Efficiency in the Clinical Supply Chain?
-
![shutterstock_515980906]()
Considerations for Manufacturing Investigational Medicinal Products for Clinical Studies
-
![Optimized-shutterstock_375131803 (1)]()
How to Maximize Randomization and Trial Management Systems in Clinical Studies
-
![shutterstock_570241078]()
Industry Viewpoints: Manufacturing IMPs for Clinical Trials
Most Read
- The Brexit Clock is Ticking, Are You Ready?
- Expert Insights: Serialization is a Necessary Step to Pharma Industry’s Adoption of Blockchain
- Considerations for Manufacturing Investigational Medicinal Products for Clinical Studies
- How to Maximize Randomization and Trial Management Systems in Clinical Studies
- The Importance of Clear Communication in the World of Clinical Supplies
Company A-Z
Latest Content
The Brexit Clock is Ticking, Are You Ready?
With Brexit only months away, CTA’s Charlie Abrines explains why the pharmaceutical industry should prepare for the worst
Clinical Trials in the US Midwest: Looking Back
As OCT & CTS Midwest gets underway, CTA pays tribute to previous articles written by authors from the US Midwest
Industry Viewpoints: Investigator-Initiated Studies – A Challenge for Supply with IMPs?
Peter Orosz, Head of Clinical Supply Chain Management & Oncology, Boehringer Ingelheim, addresses the challenges of investigator-initiated clinical trials
Serialization of Prescription Drugs: Readiness from Development into Commercialization
Hector Tamburini, Exec. Director, Regulatory Affairs & CMC, Prometheus Laboratories, examines how the industry needs to comply with regulations concerning serialization
The Million Dollar Question – How can Technology Improve Efficiency in the Clinical Supply Chain?
Rey Bacchus, Clinical Trial Supply Manager, Janssen Pharmaceutical R&D, examines what impact novel technology will have on supply chain processes
Expert Insights: Serialization is a Necessary Step to Pharma Industry’s Adoption of Blockchain
Peter Shapiro, Editor-In-Chief, PharmSource, guest writes for CTA and examines how serialization is key to a wider adoption of blockchain in pharma
Considerations for Manufacturing Investigational Medicinal Products for Clinical Studies
Kavita Vermani, Adamas Pharmaceuticals, Inc., explains the considerations required for the manufacture and release of investigational drug products
How to Maximize Randomization and Trial Management Systems in Clinical Studies
Francesco Spoto, Clinical Study Expert, highlights the advantages of using IRT solutions for pharma's SMEs and the best strategies to reap its benefits
Industry Viewpoints: Manufacturing IMPs for Clinical Trials
Gowri Sukumar, ESSA Pharmaceuticals, talks to CTA’s Henry Kerali about the challenges of manufacturing IMPs for clinical trials
The Importance of Clear Communication in the World of Clinical Supplies
Tim Holmes, Biogen, stresses the need effective communication among all parties involved in the clinical supply chain
Latest News
Read our magazine
Global Defence Technology is the essential reading material for decision-makers in the defence industry, bringing you the latest news and analysis in an exciting, interactive format.
